Alfresa Holdings Corporation (TYO:2784)

Japan flag Japan · Delayed Price · Currency is JPY
2,320.00
-46.00 (-1.94%)
At close: Dec 5, 2025
3.97%
Market Cap 421.59B
Revenue (ttm) 3.03T
Net Income (ttm) 24.85B
Shares Out 181.72M
EPS (ttm) 135.67
PE Ratio 17.10
Forward PE 13.14
Dividend 68.00 (2.87%)
Ex-Dividend Date Mar 30, 2026
Volume 313,900
Average Volume 355,705
Open 2,344.50
Previous Close 2,366.00
Day's Range 2,320.00 - 2,360.00
52-Week Range 1,897.00 - 2,403.50
Beta -0.34
RSI 60.10
Earnings Date Nov 6, 2025

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract dis... [Read more]

Sector Healthcare
Founded 2003
Employees 12,452
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 2784
Full Company Profile

Financial Performance

In 2024, Alfresa Holdings's revenue was 2.96 trillion, an increase of 3.59% compared to the previous year's 2.86 trillion. Earnings were 27.39 billion, a decrease of -7.34%.

Financial Statements

News

There is no news available yet.